Furosemide

Product NDC: 51079-072
11-digit product format: 510790072
Labeler code: 51079
Product ID: 51079-072_d347d4b5-8000-f23e-e053-2a95a90a9ad0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: furosemide
Dosage form: TABLET
Route: ORAL
Labeler: Mylan Institutional Inc.
Application: NDA018487
Marketing category: NDA
Marketing start: 1997-02-06
Marketing end: 2030-01-31
Substance: FUROSEMIDE
Active strength: 20 mg/1
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	51079-072		D	Discontinued by firm		2026-09-14
excluded package	package	51079-072	51079-072-20	D	Discontinued by firm		2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 22 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51079-072-20	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51079-072-20	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51079-072-20	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51079-072-20	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51079-072-20	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51079-072-20	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51079-072-20	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51079-072-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51079-072-20	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51079-072-20	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51079-072-20	`367a005e9d99…`	`383a685ebd0f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018487-001	FUROSEMIDE	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982
N018487-002	FUROSEMIDE	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-09-14 22:38:34	2026-08	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL		Approved before 1982	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL		Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018487-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	Approved before 1982	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018487-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	Approved before 1982	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 62 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018487-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018487-002	AB	1	`5bbf6a4d5a75…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018487-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018487-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018487-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018487-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018487-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018487-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018487-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018487-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018487-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018487-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018487-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018487-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018487-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018487-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018487-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018487-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018487-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018487-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018487-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018487-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018487-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018487-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018487-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018487-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018487-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018487-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018487-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018487-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018487-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N018487-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018487-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N018487-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018487-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N018487-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018487-001	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018487-002	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018487-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	N018487-002	AB	1	`1c564ffb4f44…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51079-072-01	EA - Each	51079-072	bbae735a-8735-4748-a671-8e95faa327cd	1	2012-07-24
51079-072-17	EA - Each	51079-072	36b6d6d7-c641-4879-b5de-175c3b292311	1	2012-07-24
51079-072-19	EA - Each	51079-072	46759293-48f9-40d3-9a14-7d02101c7352	1	2012-07-24
51079-072-20	EA - Each	51079-072	ef270483-eda6-4e80-a7a4-3109afe0e4bc	1	2012-07-24
51079-072-30	EA - Each	51079-072	3984cdca-200d-4f1b-9d9b-5e5104c711cd	1	2012-07-24
51079-072-56	EA - Each	51079-072	53dbcd65-98bd-4b7f-ab68-bc2d494bc275	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FUROSEMIDE	ACTIVE INGREDIENT	7LXU5N7ZO5	FUROSEMIDE TABLET [CARDINAL HEALTH]	7
FUROSEMIDE	ACTIVE MOIETY	7LXU5N7ZO5	FUROSEMIDE TABLET [CARDINAL HEALTH]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	FUROSEMIDE TABLET [CARDINAL HEALTH]	7
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	FUROSEMIDE TABLET [CARDINAL HEALTH]	7
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	FUROSEMIDE TABLET [CARDINAL HEALTH]	7
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	FUROSEMIDE TABLET [CARDINAL HEALTH]	7
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	FUROSEMIDE TABLET [CARDINAL HEALTH]	7
FUROSEMIDE	ACTIVE INGREDIENT	7LXU5N7ZO5	FUROSEMIDE TABLET [MYLAN INSTITUTIONAL INC.]	2
FUROSEMIDE	ACTIVE MOIETY	7LXU5N7ZO5	FUROSEMIDE TABLET [MYLAN INSTITUTIONAL INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	FUROSEMIDE TABLET [MYLAN INSTITUTIONAL INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	FUROSEMIDE TABLET [MYLAN INSTITUTIONAL INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	FUROSEMIDE TABLET [MYLAN INSTITUTIONAL INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	FUROSEMIDE TABLET [MYLAN INSTITUTIONAL INC.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	FUROSEMIDE TABLET [MYLAN INSTITUTIONAL INC.]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51079-072-20	51079007220	100 BLISTER PACK in 1 CARTON (51079-072-20) > 1 TABLET in 1 BLISTER PACK (51079-072-01)	100 blister pack	1997-02-06	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Furosemide - Cardinal Health 107, LLC	Cardinal Health 107, LLC	2024-01-24	HUMAN PRESCRIPTION DRUG LABEL	21
Furosemide - Mylan Institutional Inc.	Mylan Institutional Inc.	2023-03-31	HUMAN PRESCRIPTION DRUG LABEL	11